Neurofibromatosis Treatment Drugs Market in Asia Pacific Is Driven By Approval and Launch of New Drugs

 

Neurofibromatosis Treatment Drugs Market

Neurofibromatosis type 1is a debilitating genetic condition that can cause clinical issues such as disfigurement, motor dysfunction, pain, airway dysfunction, visual impairment and bladder or bowel dysfunction. Neurofibromatosis type 2 is associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance. Recently, in July 2021, a research in the U.S. indicated that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2. The research was conducted at Massachusetts General Hospital and Massachusetts Eye and Ear. Similarly in October 2019, SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced that the first patient has been dosed in the Phase 2b ReNeu clinical trial evaluating mirdametinib, an oral, small molecule designed to inhibit MEK1 and MEK2, in children and adult patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). Thus, R&D in neurofibromatosis treatment is expected to propel growth of the neurofibromatosis treatment drugs market.

The neurofibromatosis treatment drugs market in Europe is driven by approval and launch of new drugs. For instance, in June 2021, the European Union granted AstraZeneca and Merck’s Koselugo (selumetinib) approval for the treatment of symptomatic, inoperable plexiform neurofibromas in paediatric patients with neurofibromatosis type 1 aged three years and above.

R&D in neurofibromatosis treatment is expected to propel growth of the neurofibromatosis treatment drugs market in North America. For instance, in January 2021, a research in the U.S. demonstrated that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1. The research was conducted at Children's Hospital of Philadelphia as part of the Neurofibromatosis Clinical Trials Consortium.

The neurofibromatosis treatment drugs market in Asia Pacific is driven by approval and launch of new drugs. For instance, in July 2020, AstraZeneca was granted orphan drug designation for selumetinib in Japan for the treatment of neurofibromatosis type 1. Moreover, government investment in R&D of neurofibromatosis is also expected to aid in growth of the market in Asia Pacific. For instance, in February 2021, The Australian Government announced to invest US$ 8 million to support the Children’s Tumour Foundation and research into neurofibromatosis.

Players in the neurofibromatosis treatment drugs market are focused on adopting partnership stringiest to expand their product portfolio. For instance, in July 2021, The Children’s Tumor Foundation launched INTUITT-NF2, an innovative platform trial to evaluate multiple treatments simultaneously. This initiative, in collaboration with Takeda Pharmaceuticals, is a significant advancement in care for neurofibromatosis type 2.


Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into ...
Read more

Pressure Bandages Market : Global Industry Analysis and Opportunity Assessment

Image
  Pressure bandages are clinical gadgets used to ensure and mend a harmed region and to control draining without influencing the ordinary blood dissemination. Pressure bandages include non-follower bandages applied over an entry point or wound and is covered by spongy stretchable cement. They are basically used to pack the dead space at the site of injury or cut and forestall the arrangement of seroma and hematoma. Pressure bandages have wide applications in various clinical regions, for example, leg ulcers, muscular medical procedures, and the executives of persistent just as intense injuries, lymphedema, musculoskeletal wounds, and so forth Various sorts of pressure bandages, for example, low flexibility bandages, versatile bandages, and multicomponent multi-facet pressure bandages are accessible in the market and have explicit applications in various clinical signs. To get most extreme market share, driving organizations in the worldwide pressure bandages market have begun pr...
Read more

Botanical and Plant Derived Drugs Market by Source,Dosage - Global Industry Analysis,Size,Share

Image
The U.S. Food and Drug Administration's (FDA) organic medication pathway is as yet being refined as additional medication competitors keep on entering the clinical improvement pipeline under what many think about a simpler way to commercialization. FDA endorsement, a moderately rigid cycle by worldwide principles, by and large makes the way for endorsement in different nations. Further, the U.S. is viewed as a highest quality level for administrative survey. The worldwide market for organic and plant-determined medications Expected to develop around $39.6 billion by 2022 with a build yearly development rate (CAGR) of 6.1% This report is a scientific business instrument whose basic role is to depict the botanical and plant derived drugs market with the general plant-inferred drug industry as a scenery and the worldwide market for these medications going ahead. For the reasons for this report, botanicals are those medications that are FDA-endorsed under the plant drug pathway,...
Read more